Patent details
EP3017811 Title: APIXABAN FORMULATIONS
Basic Information
- Publication number:
- EP3017811
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP151908233
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- APIXABAN FORMULATIONS
- French Title of Invention:
- FORMULATIONS D'APIXABAN
- German Title of Invention:
- APIXABAN-FORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 24/02/2011
- Grant date:
- 05/12/2018
- EP Publication Date:
- 11/05/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/12/2018
- EP B1 Publication Date:
- 05/12/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 24/02/2031
- Renunciation date:
- Revocation date:
- 30/01/2024
- Annulment date:
Owner
- From:
- 01/03/2019
- Name:
- Bristol-Myers Squibb Holdings Ireland Unlimited Company
- Address:
- Hinterbergstrasse 16, 6312 Steinhausen, Switzerland (CH)
- Name:
- Pfizer Inc.
- Address:
- 235 East 42nd Street, New York, NY 10017, United States (US)
History of Owners
- From:
- 28/11/2018
- To:
- 01/03/2019
- Name:
- Bristol-Myers Squibb Holdings Ireland
- Address:
- Hinterbergstrasse 16, 6312 Steinhausen, Switzerland (CH)
- Name:
- Pfizer Inc.
- Address:
- 235 East 42nd Street, New York, NY 10017, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 31/01/2019
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- PATEL, Jatin
- Address:
- United States (US)
2
- Name:
- FROST, Charles
- Address:
- United States (US)
3
- Name:
- JIA, Jingpin
- Address:
- United States (US)
4
- Name:
- VEMA-VARAPU, Chandra
- Address:
- United States (US)
Priority
- Priority Number:
- 308056 P
- Priority Date:
- 25/02/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/20; A61K 31/4545; A61P 7/02;
Publication
Bulletin
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2024/06
- Publication date:
- 06/05/2024
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
European Patent Bulletin
1
- Issue number:
- 201849
- Publication date:
- 05/12/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201941
- Publication date:
- 09/10/2019
- Description:
- Opposition procedure started
3
- Issue number:
- 201940
- Publication date:
- 02/10/2019
- Description:
- Opposition procedure started
4
- Issue number:
- 202417
- Publication date:
- 24/04/2024
- Description:
- Revocation of the European patent
5
- Issue number:
- 201914
- Publication date:
- 03/04/2019
- Description:
- Transfer of Rights
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 13/02/2024
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 198 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 13/02/2019 | Outgoing Correspondence | 1 |
| 31/01/2019 | Power Of Attorney | 1 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |